Immature Platelet Fraction (IPF) as a predictor of severity in patients with COVID-19: an integrative review

Authors

DOI:

https://doi.org/10.33448/rsd-v11i1.24959

Keywords:

Biomarker; SARS-CoV-2; Coagulopathy.

Abstract

Objective: analyze the scientific evidence regarding the use of Immature Platelet Fraction (IPF) as a predictor of severity of COVID-19. Methods: This is an integrative literature review. The guiding question used was “IPF can be a parameter used as a prognosis of severity in patients with COVID-19?”. To answer this question, were selected studies Pubmed and in the Virtual Health Library (VHL). The search terms used were immature platelets, reticulated platelets, immature platelet fraction, COVID-19 and SARS-CoV-2. The terms were searched in portuguese and english, using the boolean operator “and”. Results: after applying the selection criteria, five articles were used. The studies reviewed found a significant increase in immature platelets in patients with severe COVID-19 compared to mild and moderate form of the disease. In addition, IPF proved to be differential biomarker between patients with COVID-19 and patients with cardiovascular risks. Conclusion: the need for further research was evidenced in order to accurately determine the IPF cohort values that can be used in the clinical management of patients with COVID-19.

References

Barrett, T. J., Bilaloglu, S., Cornwell, M., Burgess, H. M., Virginio, V. W., Drenkova, K., et al. & Berger, J. S. (2021). Platelets contribute to disease severity in COVID-19. Journal of Thrombosis and Haemostasis, 19(12), 3139-3153.

Cohen, A., Harari, E., Cipok, M., Laish-Farkash, A., Bryk, G., Yahud, E., Sela, Y., Lador, N. K., Mann, T., Mayo, M., & Lev, E. I. (2020). Immature platelets in patients hospitalized with COVID-19. Journal of Thrombosis and Thrombolysis, 51(3), 608-616.

Cohen, A., Harari, E., Yahud, E., Cipok, M., Bryk, G., Lador, N. K., Mann, T., Mayo, M., & Lev, E. I. (2021). Immature platelets in patients with COVID-19: association with disease severity. Journal of thrombosis and thrombolysis, 52(3), 1-7.

Da-Silva, J. L. E., & Finotti, L. F. T. (2019). Armadilhas extracelulares dos neutrófilos: descrição e envolvimento em processos autoimunes. Arquivos de Asma, Alergia e Imunologia, 3(1), 18-24.

Di Mario, A., Garzia, M., Leone, F., Arcangeli, A., Pagano, L., & Zini, G. (2009). Immature platelet fraction (IPF) in hospitalized patients with neutrophilia and suspected bacterial infection. Journal of Infection, 59(3), 201-206.

Ercole, F. F., Melo, L. S. D., & Alcoforado, C. L. G. C. (2014). Revisão integrativa versus revisão sistemática. Revista Mineira de Enfermagem, 18(1), 9-12.

Fleury, M. K. (2020). A COVID-19 e o laboratório de hematologia: uma revisão da literatura recente. Revista Brasileira de Análises Clínicas, Rio de Janeiro, 52(2), 131-137.

Guo, Y. R., Cao, Q. D., Hong, Z. S., Tan, Y. Y., Chen, S. D., Jin, H. J., Tan, K., Wang, D., & Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research, 7(1), 1-10.

Han, H., Ma, Q., Li, C., Liu, R., Zhao, L., Wang, W., Zhang, P., Liu, X., Gao, G., Liu, F., Jiang, Y., Cheng, X., Zhu, C., & Xia, Y. (2020). Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerging microbes & infections, 9(1), 1123-1130.

Handtke, S., & Thiele, T. (2020). Large and small platelets—(When) do they differ?. Journal of Thrombosis and Haemostasis, 18(6), 1256-1267.

Handtke, S., Steil, L., Palankar, R., Conrad, J., Cauhan, S., Kraus, L., Ferrara, M., Dhople, V., Wesche, J., Volker, U., Greinacher, A., & Thiele, T. (2019). Role of Platelet Size Revisited—Function and Protein Composition of Large and Small Platelets. Thrombosis and haemostasis, 119(03), 407-420.

Hille, L., Lenz, M., Vlachos, A., Grüning, B., Hein, L., Neumann, F. J., Nuhrenberg, T., & Trenk, D. (2020). Ultrastructural, transcriptional, and functional differences between human reticulated and non‐reticulated platelets. Journal of Thrombosis and Haemostasis, 18(8), 2034-2046.

Introcaso, G., Bonomi, A., Salvini, L., D’Errico, T., Cattaneo, A., Assanelli, E., Barbieri, S. S., & Biondi, M. L. (2021). High immature platelet fraction with reduced platelet count on hospital admission. Can it be useful for COVID-19 diagnosis?. International Journal of Laboratory Hematology, 43, 1319-1324.

Jin, Y., Yang, H., Ji, W., Wu, W., Chen, S., Zhang, W., & Duan, G. (2020). Virology, epidemiology, pathogenesis, and control of COVID-19. Viruses, 12(4), 372-389.

Lador, A., Leshem-Lev, D., Spectre, G., Abelow, A., Kornowski, R., & Lev, E. I. (2017). Characterization of surface antigens of reticulated immature platelets. Journal of thrombosis and thrombolysis, 44(3), 291-297.

Lima, C. M. A. D. O. (2020). Informações sobre o novo coronavírus (COVID-19). Revista Brasileira de Radiologia, 53(2), 5-6.

Meintker, L., & Krause, S. W. (2020). Reticulated platelets–clinical application and future perspectives. Journal of Laboratory Medicine, 44(5), 241-253.

Mendes, K. D. S., Silveira, R. C. D. C. P., & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto & contexto-enfermagem, 17(4),758-764.

Monteiro, L. (2017). Valores de referência dos índices plaquetários e construção de algoritmo para liberação do plaquetograma. Revista Brasileira de Análises Clínicas, 49(3), 263-267.

Ruisi, M. M., Psaila, B., Ward, M. J., Villarica, G., & Bussel, J. B. (2010). Stability of measurement of the immature platelet fraction. American journal of hematology, 85(8), 622-624.

Seo, A., Yuan, D., Daniels, S., Yuan, S., Gallagher, M., & Wong, E. C. C. (2015). Reference intervals for immature platelet fraction and immature platelet count. International journal of laboratory hematology, 37(1), 1-2.

Smid, L., Osman, L., Arend, S. M., de Groot, S., & de Boer, M. G. (2020). Evaluation of a Modified Early Warning Score (MEWS) adjusted for COVID-19 patients (CEWS) to identify risk of ICU admission or death. MedRxiv, 1-10.

Sousa, L. M. M., Marques-Vieira, C. M. A., Severino, S. S. P., & Antunes, A. V. (2017). A metodologia de revisão integrativa da literatura em enfermagem. Revista investigação em Enfermagem, 17(2), 17-26.

Tang, N., Li, D., Wang, X., & Sun, Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of thrombosis and haemostasis, 18(4), 844-847.

Welder, D., Jeon‐Slaughter, H., Ashraf, B., Choi, S. H., Chen, W., Ibrahim, I., & Bat, T. (2021). Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients. British Journal of Haematology, 194(3), 530-536.

Wu, Q., Ren, J., Hu, D., Jiang, P., Li, G., Anjum, N., Wang, G., Gu, G., Chen, J., Wu, X., Lin, S., Li, Y., Zhao, Y., & Li, J. (2015). An elevated percentage of reticulated platelet is associated with increased mortality in septic shock patients. Medicine, 94(19), 1-8.

Published

09/01/2022

How to Cite

CRUZ, L. A. da; ALMEIDA , E. B. de . Immature Platelet Fraction (IPF) as a predictor of severity in patients with COVID-19: an integrative review. Research, Society and Development, [S. l.], v. 11, n. 1, p. e39011124959, 2022. DOI: 10.33448/rsd-v11i1.24959. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/24959. Acesso em: 14 nov. 2024.

Issue

Section

Review Article